"The issue is patents," Nobel-prize winning economist Milton Friedman explained when asked in 2004 why he opposed drug reimportation, the practice of bringing back prescription drugs originally manufactured in the U.S. and exported to other countries to sale.
The Trump administration is trying to institute a dose of free market reform that promises to disrupt American health care. In a flurry of pro-consumer moves, improving price transparency has been at the center of the administration's plan to reduce the cost of health care through competition.
Single-payer health care is when the government acts as the only payer of health care costs in the economy. Rather than individuals purchasing insurance for payment of medical expenses through their employer or on the open market, the federal government typically covers all such costs.
Timothy Taylor, the Conversable Economist, posted today on some highlights from the late Uwe Reinhardt’s last book, Priced Out: The Economic and Ethical Costs of American Health Care. He, following the lead of the Milken Institute Review in its excerpt of the book, shows charts comparing the cost of various health care goods and services in the United States to the cost in other countries.
The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.